As of August 28, 2026, Cytokinetics, Incorporated (CYTK) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Cytokinetics, Incorporated has a market capitalization of $10.42B, 139.02M shares outstanding, 453 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise
model 35%
• Low cash runway: 6 months remaining
🔁 Convertible Conversion
model 15%
• Convertible debt present: 7.0% potential dilution
Market Data
Market Cap$10.42B
Shares Outstanding139.02M
Float123.86M
Cash$255.27M
Debt$275.56M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 9.9% shares (2026Q1 vs prior)
453 institutional holders · 177.68M shares
#1
T. Rowe Price Investment Management, Inc.
17.52M shares
#2
BlackRock, Inc.
16.55M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
10.98M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest15.30M
Days to Cover9.6
% of Float12.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
Form 4
INSIDER TRANSACTION
2026-08-18
Form 4
INSIDER TRANSACTION
2026-08-18
Form 4
INSIDER TRANSACTION
2026-08-10
Form 4
INSIDER TRANSACTION
2026-08-10
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual CYTK Dilution Snapshot
Cytokinetics, Incorporated (CYTK) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CYTK: Form 4 on 2026-08-18; Form 4 on 2026-08-18; Form 4 on 2026-08-10.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track CYTK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CYTK — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for CYTK
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.